The epigenetic determinants for systemic juvenile idiopathic arthritis phenotyping and treatment response
- Standort
-
Deutsche Nationalbibliothek Frankfurt am Main
- Umfang
-
1 Online-Ressource.
- Sprache
-
Englisch
- Erschienen in
-
The epigenetic determinants for systemic juvenile idiopathic arthritis phenotyping and treatment response ; volume:25 ; number:1 ; day:6 ; month:8 ; year:2024 ; pages:1-10 ; date:12.2024
BMC musculoskeletal disorders ; 25, Heft 1 (6.8.2024), 1-10, 12.2024
- Urheber
-
Mosa, Doaa Mosad
Mohsen, Shorouk
Taman, Mohamed
Khaled, Nada
Gaafar, Sherine Mohamed
Abdelhafez, Mona S.
Elmowafy, Rasha
Elnagdy, Marwa H.
Sobh, Ali
- Beteiligte Personen und Organisationen
-
SpringerLink (Online service)
- DOI
-
10.1186/s12891-024-07702-9
- URN
-
urn:nbn:de:101:1-2410262101525.597238591738
- Rechteinformation
-
Open Access; Der Zugriff auf das Objekt ist unbeschränkt möglich.
- Letzte Aktualisierung
-
15.08.2023, 07:52 MESZ
Datenpartner
Dieses Objekt wird bereitgestellt von:
Deutsche Nationalbibliothek. Bei Fragen zum Objekt wenden Sie sich bitte an den Datenpartner.
Deutsche Nationalbibliothek. Bei Fragen zum Objekt wenden Sie sich bitte an den Datenpartner.
Beteiligte
- Mosa, Doaa Mosad
- Mohsen, Shorouk
- Taman, Mohamed
- Khaled, Nada
- Gaafar, Sherine Mohamed
- Abdelhafez, Mona S.
- Elmowafy, Rasha
- Elnagdy, Marwa H.
- Sobh, Ali
- SpringerLink (Online service)
Ähnliche Objekte (12)
Glucose metabolism in systemic juvenile idiopathic arthritis
Genetic architecture distinguishes systemic juvenile idiopathic arthritis from other forms of juvenile idiopathic arthritis: clinical and therapeutic implications
Novel IL10 gene family associations with systemic juvenile idiopathic arthritis
Extreme thrombocytosis in systemic juvenile idiopathic arthritis. A case report
Mouse models of systemic juvenile idiopathic arthritis and macrophage activation syndrome
The role of extracellular histones in systemic-onset juvenile idiopathic arthritis
Tocilizumab-induced hypofibrinogenemia in patients with systemic-onset juvenile idiopathic arthritis
Biologic switching patterns among children with non-systemic juvenile idiopathic arthritis
Oral or Parenteral Methotrexate for treatment of Non- Systemic Juvenile Idiopathic Arthritis
INFRAFRONTIER quality principles in systemic phenotyping
Inflammatory bowel disease following anti-interleukin-1-treatment in systemic juvenile idiopathic arthritis
Sequential Tocilizumab and Tofacitinib Treatment for Systemic Juvenile Idiopathic Arthritis: a Case Report
Glucose metabolism in systemic juvenile idiopathic arthritis
Genetic architecture distinguishes systemic juvenile idiopathic arthritis from other forms of juvenile idiopathic arthritis: clinical and therapeutic implications
Novel IL10 gene family associations with systemic juvenile idiopathic arthritis
Extreme thrombocytosis in systemic juvenile idiopathic arthritis. A case report
Mouse models of systemic juvenile idiopathic arthritis and macrophage activation syndrome
The role of extracellular histones in systemic-onset juvenile idiopathic arthritis
Tocilizumab-induced hypofibrinogenemia in patients with systemic-onset juvenile idiopathic arthritis
Biologic switching patterns among children with non-systemic juvenile idiopathic arthritis
Oral or Parenteral Methotrexate for treatment of Non- Systemic Juvenile Idiopathic Arthritis
INFRAFRONTIER quality principles in systemic phenotyping
Inflammatory bowel disease following anti-interleukin-1-treatment in systemic juvenile idiopathic arthritis
Sequential Tocilizumab and Tofacitinib Treatment for Systemic Juvenile Idiopathic Arthritis: a Case Report
Glucose metabolism in systemic juvenile idiopathic arthritis
Genetic architecture distinguishes systemic juvenile idiopathic arthritis from other forms of juvenile idiopathic arthritis: clinical and therapeutic implications
Novel IL10 gene family associations with systemic juvenile idiopathic arthritis
Extreme thrombocytosis in systemic juvenile idiopathic arthritis. A case report
Mouse models of systemic juvenile idiopathic arthritis and macrophage activation syndrome
The role of extracellular histones in systemic-onset juvenile idiopathic arthritis
Tocilizumab-induced hypofibrinogenemia in patients with systemic-onset juvenile idiopathic arthritis
Biologic switching patterns among children with non-systemic juvenile idiopathic arthritis
Oral or Parenteral Methotrexate for treatment of Non- Systemic Juvenile Idiopathic Arthritis
INFRAFRONTIER quality principles in systemic phenotyping
Inflammatory bowel disease following anti-interleukin-1-treatment in systemic juvenile idiopathic arthritis